Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) does not appear to reduce the effectiveness of oral contraceptive pills in the way that tirzepatide does. Current NHS guidance makes a clear distinction between the two medicines on this point. That said, there are still important contraception considerations for anyone taking a GLP-1 medicine for weight loss, and your prescriber is the right person to talk them through with you. These are prescription-only medicines that require a full clinical assessment before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misunderstanding circulating about Wegovy and birth control is that it carries the same specific pill-absorption warning as Mounjaro (tirzepatide). It does not. NHS England's guidance on weight-management injections draws an explicit line between the two: for tirzepatide, women taking oral contraceptives are advised to use an additional non-oral method (such as condoms) for the first four weeks of treatment and for four weeks after every dose increase. That instruction reflects evidence that tirzepatide may slow absorption of the pill enough to matter clinically.
For semaglutide, NHS guidance does not issue an equivalent specific warning about reduced pill effectiveness. If you have been told by a friend or read online that Wegovy cancels out the contraceptive pill the same way Mounjaro might, that is not what the current clinical picture supports. The two medicines work through related but distinct mechanisms, and their effects on oral drug absorption differ.
That distinction matters, but it is not a green light to stop thinking about contraception altogether. Read on.
Wegovy slows gastric emptying. That is part of how it works: food moves through your stomach more slowly, which prolongs fullness and reduces appetite. The pharmacological knock-on is that anything you swallow — food, other medicines, supplements — may be absorbed differently than it would be on an empty, normally functioning stomach.
In principle, this could affect any oral medicine taken at the same time as a dose, including the contraceptive pill. In practice, the clinical evidence reviewed for semaglutide has not produced the same specific signal seen with tirzepatide, which is why the NHS guidance separates them. But "no specific warning" is not the same as "no consideration needed." If you take a time-sensitive oral medicine alongside Wegovy, it is always worth raising with your prescriber or GP. A closer look at whether Wegovy makes the pill less effective covers the evidence behind this in more depth.
For most people on oral contraceptives, semaglutide is not expected to interfere. Still, anyone starting Wegovy should have an honest conversation about their full medicines list, including contraception, during their consultation.
The MHRA advises that women of childbearing age should use reliable contraception while taking GLP-1 medicines for weight management, and for a period after stopping, before trying to conceive. This is not because these medicines harm fertility in any proven way; it is because they are not recommended during pregnancy, and the wash-out period gives the medicine time to leave your system before conception is attempted.
Wegovy's prescribing information is specific: the medicine is not recommended during pregnancy or breastfeeding. Under-18s are also outside the licensed population. If you are thinking about starting a family in the near future, that timeline is an important part of the clinical conversation before treatment begins, not a reason to avoid the topic.
The question of whether semaglutide cancels out birth control is one our prescribers hear regularly, and NHS England's guidance provides the clearest current answer: the tirzepatide-specific pill-absorption warning does not extend to semaglutide. NHS England's guidance on weight-management injections is the primary reference on this point and is updated as new evidence emerges.
If you are on any form of hormonal contraception (pill, patch, ring, implant or hormonal IUD) tell your prescriber at consultation. Not because semaglutide is known to interfere with all of these, but because a thorough medicines review is standard practice before any prescription is issued. The implant and hormonal IUD, for instance, are not affected by gastric emptying at all, since they do not rely on oral absorption. Patches work transdermally. The picture varies by contraceptive method.
It is also worth noting that significant weight change itself can sometimes influence how certain hormonal preparations perform, though the evidence here is less clear-cut than the medicine-absorption question. Again: something to raise, not something to assume.
If you want to understand the broader cost and access picture for Wegovy before booking, the Wegovy cost guide for UK patients covers what private treatment typically involves. When you are ready to discuss your own situation, start your free consultation with our prescribers, a real clinician reads your answers the same day, not a piece of software. Our Wegovy overview is a useful starting point if you want the full clinical picture first. You can also read more about semaglutide as the medicine behind both Wegovy and Ozempic, and how they differ in their licensed uses.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.